ATC code L02

From Wikipedia, the free encyclopedia

ATC code L02 Endocrine therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup L02 is part of the anatomical group L Antineoplastic and immunomodulating agents.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QL02.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

L02A Hormones and related agents[edit]

L02AA Estrogens[edit]

L02AA01 Diethylstilbestrol
L02AA02 Polyestradiol phosphate
L02AA03 Ethinylestradiol
L02AA04 Fosfestrol

L02AB Progestogens[edit]

L02AB01 Megestrol
L02AB02 Medroxyprogesterone
L02AB03 Gestonorone

L02AE Gonadotropin-releasing hormone analogues[edit]

L02AE01 Buserelin
L02AE02 Leuprorelin
L02AE03 Goserelin
L02AE04 Triptorelin
L02AE05 Histrelin
L02AE51 Leuprorelin and bicalutamide

L02AX Other hormones[edit]

L02B Hormone antagonists and related agents[edit]

L02BA Anti-estrogens[edit]

L02BA01 Tamoxifen
L02BA02 Toremifene
L02BA03 Fulvestrant
L02BA04 Elacestrant

L02BB Anti-androgens[edit]

L02BB01 Flutamide
L02BB02 Nilutamide
L02BB03 Bicalutamide
L02BB04 Enzalutamide
L02BB05 Apalutamide
L02BB06 Darolutamide

L02BG Aromatase inhibitors[edit]

L02BG01 Aminogluthetimide
L02BG02 Formestane
L02BG03 Anastrozole
L02BG04 Letrozole
L02BG05 Vorozole
L02BG06 Exemestane

L02BX Other hormone antagonists and related agents[edit]

L02BX01 Abarelix
L02BX02 Degarelix
L02BX03 Abiraterone
L02BX04 Relugolix
L02BX53 Abiraterone and prednisolone

References[edit]

  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. ^ "ATC/DDD Index 2022: code L02". WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^ "ATCvet Index 2022: code QL02". WHO Collaborating Centre for Drug Statistics Methodology.